First Trust Advisors LP purchased a new position in shares of athenahealth, Inc. (NASDAQ:ATHN) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 1,560 shares of the health services provider’s stock, valued at approximately $219,000.

Several other hedge funds have also modified their holdings of ATHN. FNY Partners Fund LP increased its position in shares of athenahealth by 1,900.0% during the first quarter. FNY Partners Fund LP now owns 1,000 shares of the health services provider’s stock worth $112,000 after purchasing an additional 950 shares in the last quarter. Bessemer Group Inc. increased its position in shares of athenahealth by 13.7% during the second quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock worth $132,000 after purchasing an additional 113 shares in the last quarter. Seven Bridges Advisors LLC increased its position in shares of athenahealth by 5.4% during the second quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock worth $183,000 after purchasing an additional 67 shares in the last quarter. World Asset Management Inc acquired a new position in shares of athenahealth during the second quarter worth $253,000. Finally, Comerica Bank increased its position in shares of athenahealth by 0.6% during the first quarter. Comerica Bank now owns 2,487 shares of the health services provider’s stock worth $302,000 after purchasing an additional 14 shares in the last quarter.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/10/01/first-trust-advisors-lp-purchases-shares-of-1560-athenahealth-inc-athn.html.

Shares of athenahealth, Inc. (NASDAQ ATHN) opened at 124.36 on Friday. The stock’s 50 day moving average is $138.24 and its 200 day moving average is $129.15. The stock has a market capitalization of $4.97 billion, a price-to-earnings ratio of 157.82 and a beta of 1.79. athenahealth, Inc. has a 1-year low of $90.11 and a 1-year high of $158.66.

athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.39 by $0.12. The business had revenue of $301.10 million for the quarter, compared to the consensus estimate of $298.68 million. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. The business’s quarterly revenue was up 15.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.34 earnings per share. On average, equities analysts forecast that athenahealth, Inc. will post $1.91 EPS for the current year.

In other news, SVP Jonathan D. Porter sold 300 shares of athenahealth stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $143.13, for a total value of $42,939.00. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Jonathan Bush sold 4,000 shares of athenahealth stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $140.52, for a total transaction of $562,080.00. Following the completion of the sale, the chief executive officer now directly owns 319,807 shares in the company, valued at approximately $44,939,279.64. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,722 shares of company stock worth $2,221,721. Insiders own 3.20% of the company’s stock.

ATHN has been the topic of a number of recent analyst reports. TheStreet raised athenahealth from a “c” rating to a “b-” rating in a research report on Thursday, July 20th. SunTrust Banks, Inc. reaffirmed a “buy” rating and set a $150.00 price target on shares of athenahealth in a research report on Monday, July 17th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $152.00 price target on shares of athenahealth in a research report on Friday, July 14th. Citigroup Inc. reaffirmed a “buy” rating and set a $169.00 price target (up from $163.00) on shares of athenahealth in a research report on Monday, July 10th. Finally, BidaskClub raised athenahealth from a “hold” rating to a “buy” rating in a research report on Saturday, June 24th. Three analysts have rated the stock with a sell rating, twelve have given a hold rating and twelve have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $149.91.

athenahealth Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Stock Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related stocks with our FREE daily email newsletter.